Skip to main content
Top
Published in: World Journal of Surgery 5/2006

01-05-2006

Sentinel Lymph Node Biopsy May Be Used to Support the Decision to Perform Modified Radical Neck Dissection in Differentiated Thyroid Carcinoma

Author: Radan Dzodic

Published in: World Journal of Surgery | Issue 5/2006

Login to get access

Abstract

Background

The prognostic significance of lymph node metastases (LNM) in follicle cell-derived differentiated thyroid carcinoma (DTC) is still controversial. The management of cervical lymph nodes varies from “berry picking” to modified radical neck dissection (MRND). The incidence of LNM in papillary thyroid carcinoma varies from 27% to 80%. The importance of sentinel lymph node (SLN) biopsy for decisions about the surgical management of lymph nodes in DTC has been the subject of several previous studies.

Patients and Methods

In 40 patients with DTC methylene blue dye was applied peritumorally. Both SLN and non-SLN in the lower third of the jugulo-carotid chain were dissected prior to total thyroidectomy and routine dissection of the central neck compartment and examined by frozen-section and standard histology. MRND was performed in 9 cases of LNM in the lateral neck compartment.

Results

The SLN identification rate was 92.5%. Metastases in SLNs were revealed by frozen-section histology in 7 cases, leading to immediate MRND. The findings were confirmed on standard HE examination. In 2 false-negative cases SLN metastases were revealed on standard histology and MRND was performed 1 week later. The specificity of the method was 100%, sensitivity 77.7%, negative predictive value 94%, positive predictive value 100%, with overall accuracy of 95%.

Conclusion

Our results seem to imply that SLN biopsy in the jugulo-carotid chain using methylene blue dye mapping may be a feasible and valuable method for estimating lymph node status in the lateral neck compartment. It may be helpful in the detection of true-positive but nonpalpable lymph nodes, and in such cases may support the decision to perform MRND in patients with DTC.
Literature
1.
go back to reference Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 2000;6:469–476PubMed Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 2000;6:469–476PubMed
2.
go back to reference Cady B. Presidential address: beyond risk groups—a new look at differentiated thyroid cancer. Surgery 1998;124:947–957PubMed Cady B. Presidential address: beyond risk groups—a new look at differentiated thyroid cancer. Surgery 1998;124:947–957PubMed
3.
go back to reference Noguchi S, Yamashita H, et al. Changing trend of presentation of papillary carcinoma of the thyroid in the last 5 decades: experience in one institution. Int J Cancer 2002;13:216 Noguchi S, Yamashita H, et al. Changing trend of presentation of papillary carcinoma of the thyroid in the last 5 decades: experience in one institution. Int J Cancer 2002;13:216
4.
go back to reference Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control 2000;7:240–245PubMed Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control 2000;7:240–245PubMed
5.
go back to reference McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991;162:353–356PubMedCrossRef McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991;162:353–356PubMedCrossRef
6.
go back to reference Akslen LA, Haldorsen T, Thoresen SO, et al. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res 1991;51:1234–1241PubMed Akslen LA, Haldorsen T, Thoresen SO, et al. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res 1991;51:1234–1241PubMed
7.
go back to reference Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg 1988;12:825–829PubMedCrossRef Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg 1988;12:825–829PubMedCrossRef
8.
go back to reference Attie JN. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer 1988;24:315–324CrossRef Attie JN. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer 1988;24:315–324CrossRef
9.
go back to reference Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1999;114:1050–1058 Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1999;114:1050–1058
10.
go back to reference Noguchi S, Murakami S, Yamashita H, et al. Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 1998;133:276–280PubMedCrossRef Noguchi S, Murakami S, Yamashita H, et al. Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 1998;133:276–280PubMedCrossRef
11.
go back to reference Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804PubMed Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804PubMed
12.
go back to reference Lacour J, L’Heritier M, Petit JY, et al. Surgical treatment of differentiated thyroid cancer at the Institut Gustave-Roussy. Ann Radiol (Paris) 1977;20:767–770 Lacour J, L’Heritier M, Petit JY, et al. Surgical treatment of differentiated thyroid cancer at the Institut Gustave-Roussy. Ann Radiol (Paris) 1977;20:767–770
13.
go back to reference Scheumenn GFW, Gimm O, Wegner G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–567CrossRef Scheumenn GFW, Gimm O, Wegner G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–567CrossRef
14.
go back to reference Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–466PubMed Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–466PubMed
15.
go back to reference Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–399PubMed Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–399PubMed
16.
go back to reference Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401PubMed Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401PubMed
17.
go back to reference Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radio localisation of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993;2:335–340PubMedCrossRef Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radio localisation of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993;2:335–340PubMedCrossRef
18.
go back to reference Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288–292PubMedCrossRef Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288–292PubMedCrossRef
19.
go back to reference Fukui Y, Yamakawa T, Taniki T, et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001;92:2868–2874PubMedCrossRef Fukui Y, Yamakawa T, Taniki T, et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001;92:2868–2874PubMedCrossRef
20.
go back to reference Arch-Ferrer J, Velazquez D, Fajardo R, et al. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 2000;130:907–913CrossRef Arch-Ferrer J, Velazquez D, Fajardo R, et al. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 2000;130:907–913CrossRef
21.
go back to reference Catarci M, Zaraca F, Angeloni R, et al. Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid carcinoma. A pilot study. J Surg Oncol 2001;77:21–24PubMedCrossRef Catarci M, Zaraca F, Angeloni R, et al. Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid carcinoma. A pilot study. J Surg Oncol 2001;77:21–24PubMedCrossRef
22.
go back to reference Takami H, Sasaki K, Ikeda Y, et al. Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J Surg 2003;26:145–148PubMedCrossRef Takami H, Sasaki K, Ikeda Y, et al. Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J Surg 2003;26:145–148PubMedCrossRef
23.
go back to reference Tsugawa K, Ohnishi I, Nakamura M, et al. Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland. Biomed Pharmacother 2002;56(Suppl 1):100–103CrossRef Tsugawa K, Ohnishi I, Nakamura M, et al. Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland. Biomed Pharmacother 2002;56(Suppl 1):100–103CrossRef
24.
go back to reference Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000;24:1396–1401PubMedCrossRef Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000;24:1396–1401PubMedCrossRef
25.
go back to reference Mirallie E, Visset J, Sagan C, et al. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999;23(9):970–973PubMedCrossRef Mirallie E, Visset J, Sagan C, et al. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999;23(9):970–973PubMedCrossRef
26.
go back to reference Noguchi M, Kumaki T, Taniya T, et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 1990;125:804–806PubMed Noguchi M, Kumaki T, Taniya T, et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 1990;125:804–806PubMed
27.
go back to reference Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 1987;67:251–261PubMed Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 1987;67:251–261PubMed
28.
go back to reference Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194–1198; discussion 1199PubMedCrossRef Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194–1198; discussion 1199PubMedCrossRef
29.
go back to reference Wiseman S, Hicks W, Chu Q, et al. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 2002;11:137–142PubMedCrossRef Wiseman S, Hicks W, Chu Q, et al. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 2002;11:137–142PubMedCrossRef
30.
go back to reference Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 2003;10:242–247PubMedCrossRef Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 2003;10:242–247PubMedCrossRef
31.
go back to reference Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, Domino EF. Allergic reactions to isosulfan blue during sentinel node biopsy—a common event. Surgery 2001;130:439–442PubMedCrossRef Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, Domino EF. Allergic reactions to isosulfan blue during sentinel node biopsy—a common event. Surgery 2001;130:439–442PubMedCrossRef
Metadata
Title
Sentinel Lymph Node Biopsy May Be Used to Support the Decision to Perform Modified Radical Neck Dissection in Differentiated Thyroid Carcinoma
Author
Radan Dzodic
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 5/2006
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0298-0

Other articles of this Issue 5/2006

World Journal of Surgery 5/2006 Go to the issue